![Shai Novik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shai Novik
Vorsitzender bei
ENLIVEX LTD.
Vermögen: 6 Mio $ am 31.05.2026
Profil
Shai A. Novik was the founder of OPKO Biologics Ltd., serving as President from 2001 to 2014.
Mr. Novik is the founder of InnoVision Labs, Inc., serving as Chairman.
Mr. Novik is also the founder of Stentomics, Inc. Mr. Novik is previously the Executive Chairman of Enlivex Therapeutics Ltd. since 2014, Director of Odysseus Ventures Ltd., and Director of InnoVision Labs, Inc. since 2013.
Former positions include Chairman of Autovative Products, Inc. in 2013, Chairman of Enlivex Therapeutics Ltd., Managing Director of A-Online Capital (A.O.C.) Ltd. in 2002, Director of Cazador Acquisition Corp.
Ltd. from 2010 to 2012, Director of Ucansi, Inc., Chief Operating Officer & Head-Strategic Planning of THCG, Inc. from 1998 to 2000, and Chief Operating Officer of Rogerscasey, Inc. Education includes an MBA from Cornell University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ENLIVEX LTD. 2,89 % | 18.03.2026 | 6.974.017 ( 2,89 % ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von Shai Novik
| Unternehmen | Position | Beginn |
|---|---|---|
| ENLIVEX LTD. | Vorsitzender | 01.01.2014 |
| INNOVISION LABS, INC. | Direktor/Vorstandsmitglied | 01.01.2013 |
Stentomics, Inc. | Gründer | 06.09.2010 |
Odysseus Ventures Ltd. | Direktor/Vorstandsmitglied | 06.09.2010 |
Ehemalige bekannte Positionen von Shai Novik
| Unternehmen | Position | Ende |
|---|---|---|
OPKO Biologics Ltd.
 OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Gründer | 01.01.2014 |
Ucansi, Inc.
 Ucansi, Inc. Packaged SoftwareTechnology Services Develops solutions for treating presbyopia | Direktor/Vorstandsmitglied | 12.08.2013 |
Autovative Products, Inc.
 Autovative Products, Inc. Wholesale DistributorsDistribution Services Produces and distributes automotive parts | Vorsitzender | 12.08.2013 |
Cazador Acquisition Corp. Ltd.
 Cazador Acquisition Corp. Ltd. Financial ConglomeratesFinance Operates as a blank check company | Direktor/Vorstandsmitglied | 04.10.2012 |
| A-ONLINE CAPITAL (A.O.C) LTD. | Präsident | 01.01.2002 |
Ausbildung von Shai Novik
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
THCG, Inc.
 THCG, Inc. Finance/Rental/LeasingFinance Provides venture funding, venture development, and venture banking services | Finance |
A-Online Capital (A.O.C.) Ltd.
 A-Online Capital (A.O.C.) Ltd. Packaged SoftwareTechnology Services Develops trading and investment portfolio analysis software solutions | Technology Services |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
Autovative Products, Inc.
Autovative Products, Inc. Wholesale DistributorsDistribution Services Produces and distributes automotive parts | Distribution Services |
Cazador Acquisition Corp. Ltd.
Cazador Acquisition Corp. Ltd. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rogerscasey, Inc.
 Rogerscasey, Inc. Investment ManagersFinance Provides investment consulting services | Finance |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Stentomics, Inc. | |
Ucansi, Inc.
Ucansi, Inc. Packaged SoftwareTechnology Services Develops solutions for treating presbyopia | Technology Services |
Odysseus Ventures Ltd. | |
InnoVision Labs, Inc.
 InnoVision Labs, Inc. Packaged SoftwareTechnology Services Operates as visual neuroscience software technology company | Technology Services |
Enlivex Therapeutics Ltd.
 Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
